Novel insights for systemic inflammation in sepsis and hemorrhage

Mediators of Inflammation

Volumn 2010, Issue , 2010, Pages

  Ulloa, Luis ^a   Cai, Bolin ^a   Deitch, Edwin A ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BUNGAROTOXIN RECEPTOR AGONIST; CHOLINE; CORTICOSTERONE; CYTOKINE; ENDOTOXIN; HETASTARCH; HIGH MOBILITY GROUP B1 PROTEIN; LIPOPOLYSACCHARIDE; MORPHINE; NICOTINIC AGENT; PHENOBARBITAL; PYRUVIC ACID DERIVATIVE; PYRUVIC ACID ETHYL ESTER; RECOMBINANT HIGH MOBILITY GROUP B1 PROTEIN; RECOMBINANT INTERLEUKIN 6; RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR INHIBITOR; UNCLASSIFIED DRUG; ZYMOSAN; ANTIINFLAMMATORY AGENT; BUNGAROTOXIN RECEPTOR; NICOTINIC RECEPTOR; NOOTROPIC AGENT;

ANESTHESIA INDUCTION; ANTIINFLAMMATORY ACTIVITY; BACTERIAL INFECTION; BLEEDING; CLINICAL TRIAL; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG EFFICACY; DRUG MEGADOSE; ENDOTOXEMIA; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL INFECTION; HEMORRHAGIC SHOCK; HUMAN; HYPOVOLEMIA; HYPOVOLEMIC SHOCK; INFLAMMATION; INNATE IMMUNITY; INTENSIVE CARE; LOW DRUG DOSE; LUNG INJURY; MEDIATOR; MORTALITY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESUSCITATION; RETICULOENDOTHELIAL SYSTEM; REVIEW; SEPSIS; SEPTIC SHOCK; SIGNAL TRANSDUCTION; SYMPTOM; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; ANIMAL; DISEASE MODEL; DRUG ANTAGONISM; IMMUNOLOGY; METABOLISM;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CHOLINE; CYTOKINES; DISEASE MODELS, ANIMAL; HEMORRHAGE; HMGB1 PROTEIN; HUMANS; INFLAMMATION; NICOTINIC AGONISTS; NOOTROPIC AGENTS; PYRUVATES; RECEPTORS, NICOTINIC; SEPSIS;

EID: 77954558483     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2010/642462     Document Type: Review

References (100)

1. Sands K. E., Bates D. W., Lanken P. N., Epidemiology of sepsis syndrome in 8 academic medical centers Journal of the American Medical Association 1997 278 3 234 240
2. Friedman G., Silva E., Vincent J.-L., Has the mortality of septic shock changed with time? Critical Care Medicine 1998 26 12 2078 2086
3. Abraham E., Matthay M. A., Consensus conference definitions for sepsis, septic shock, acute lung injury, and acute respiratory distress syndrome: Time for a reevaluation Critical Care Medicine 2000 28 1 232 235
4. Matot I., Sprung C. L., Definition of sepsis Intensive Care Medicine 2001 27 7 S3 S9
5. Cai B., Brunner M., Wang H., Wang P., Deitch E. A., Ulloa L., Ethyl pyruvate improves survival in awake hemorrhage Journal of Molecular Medicine 2009 87 4 423 433
6. Cai B., Chen F., Ji Y., Alpha7 cholinergic-agonist prevents systemic inflammation and improves survival during resuscitation Journal of Cellular and Molecular Medicine 2009 13 9 3774 3785
7. Wang H., Bloom O., Zhang M., Identification of HMG-1 as a late mediator of endotoxin lethality in mice Science 1999 285 5425 248 251
8. Brandtzaeg P., van Deuren M., Current concepts in the role of the host response in Neisseria meningitidis septic shock Current Opinion in Infectious Diseases 2002 15 3 247 252
9. Tracey K. J., Cerami A., Tumor necrosis factor, other cytokines and disease Annual Review of Cell Biology 1993 9 317 343
10. Tracey K. J., Fong Y., Hesse D. G., Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia Nature 1987 330 6149 662 664
11. Hotchkiss R. S., Karl I. E., The pathophysiology and treatment of sepsis The New England Journal of Medicine 2003 348 2 138 150
12. Yang H., Ochani M., Li J., Reversing established sepsis with antagonists of endogenous high-mobility group box 1 Proceedings of the National Academy of Sciences of the United States of America 2004 101 1 296 301
13. Sappington P. L., Yang R., Yang H., Tracey K. J., Delude R. L., Fink M. P., HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice Gastroenterology 2002 123 3 790 802
14. Degryse B., Bonaldi T., Scaffidi P., The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells Journal of Cell Biology 2001 152 6 1197 1206
15. Li J., Wang H., Mason J. M., Recombinant HMGB1 with cytokine-stimulating activity Journal of Immunological Methods 2004 289 1-2 211 223
16. Ulloa L., Ochani M., Yang H., Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation Proceedings of the National Academy of Sciences of the United States of America 2002 99 19 12351 12356
17. Ulloa L., Ochani M., Fink M. P., Tracey K. J., Ethyl pyruvate protects against lethal systemic inflammation by preventing HMGB1 release Annals of the New York Academy of Sciences 2003 987 19 319 321
18. Allen P. D., Bustin S. A., Newland A. C., The role of apoptosis (programmed cell death) in haematopoiesis and immune system Blood 1993 81 63 73
19. Chung C.-S., Song G. Y., Moldawer L. L., Chaudry I. H., Ayala A., Neither Fas ligand nor endotoxin is responsible for inducible peritoneal phagocyte apoptosis during sepsis/peritonitis Journal of Surgical Research 2000 91 2 147 153
20. Hernandez-Caselles T., Stutman O., Immune functions of tumor necrosis factor: I. Tumor necrosis factor induces apoptosis of mouse thymocytes and can also stimulate or inhibit IL- 6-induced proliferation depending on the concentration of mitogenic costimulation Journal of Immunology 1993 151 8 3999 4012
21. Huston J. M., Ochani M., Rosas-Ballina M., Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis Journal of Experimental Medicine 2006 203 7 1623 1629
22. Abraham E., Arcaroli J., Carmody A., Wang H., Tracey K. J., HMG-1 as a mediator of acute lung inflammation Journal of Immunology 2000 165 6 2950 2954
23. Ueno H., Matsuda T., Hashimoto S., Contributions of high mobility group box protein in experimental and clinical acute lung injury American Journal of Respiratory and Critical Care Medicine 2004 170 12 1310 1316
24. Lin X., Yang H., Sakuragi T., -chemokine receptor blockade reduces high mobility group box 1 protein-induced lung inflammation and injury and improves survival in sepsis American Journal of Physiology 2005 289 4 L583 L590
25. Deng X., Wang X., Lasson A., Sun Z., Soltesz V., Andersson R., The involvement of multiple protease-antiprotease systems and gut origin sepsis in zymosan-associated endothelial barrier injury and multiple organ dysfunction in rats Shock 2001 16 4 298 303
26. Remichkova M., Yordanov M., Dimitrova P., Etoposide attenuates zymosan-induced shock in mice Inflammation 2008 31 1 57 64
27. Nieuwenhuijzen G. A. P., Haskel Y., Lu Q., Macrophage elimination increases bacterial translocation and gut-origin septicemia but attenuates symptoms and mortality rate in a model of systemic inflammation Annals of Surgery 1993 218 6 791 799
28. Gautier E. L., Huby T., Saint-Charles F., Ouzilleau B., Chapman M. J., Lesnik P., Enhanced dendritic cell survival attenuates lipopolysaccharide- induced immunosuppression and increases resistance to lethal endotoxic shock Journal of Immunology 2008 180 10 6941 6946
29. Mifkovic A., Skultety J., Pindak D., Pechan J., Specific aspects of acute pancreatitis Bratislavsk Lekrske Listy 2009 110 9 544 552
30. Oberholzer A., Oberholzer C., Moldawer L. L., Sepsis syndromes: Understanding the role of innate and acquired immunity Shock 2001 16 2 83 96
31. Nduka O. O., Parrillo J. E., The pathophysiology of septic shock Critical Care Clinics 2009 25 4 677 702
32. Poli-de-Figueiredo L. F., Garrido A. G., Nakagawa N., Sannomiya P., Experimental models of sepsis and their clinical relevance Shock 2008 30 7 53 59
33. Lindsey D. C., Emerson T. E. Jr., Thompson T. E., Characterization of an endotoxemic baboon model of metabolic and organ dysfunction Circulatory Shock 1991 34 3 298 310
34. Remick D. G., Strieter R. M., Eskandari M. K., Role of tumor necrosis factor- in lipopolysaccharide-induced pathologic alterations American Journal of Pathology 1990 136 1 49 60
35. Levi M., de Jonge E., van der Poll T., Sepsis and disseminated intravascular coagulation Journal of Thrombosis and Thrombolysis 2003 16 1-2 43 47
36. Singleton K. D., Wischmeyer P. E., Distance of cecum ligated influences mortality, tumor necrosis factor-alpha and interleukin-6 expression following cecal ligation and puncture in the rat European Surgical Research 2003 35 6 486 491
37. Czermak B. J., Sarma V., Pierson C. L., Protective effects of C5a blockade in sepsis Nature Medicine 1999 5 7 788 792
38. Huber-Lang M., Sarma V. J., Lu K. T., Role of C5a in multiorgan failure during sepsis Journal of Immunology 2001 166 2 1193 1199
39. Huber-Lang M. S., Sarma J. V., McGuire S. R., Protective effects of anti-C5a peptide antibodies in experimental sepsis The FASEB journal 2001 15 3 568 570
40. Ulloa L., Tracey K. J., The cytokine profile: a code for sepsis Trends in Molecular Medicine 2005 11 2 56 63
41. Ulloa L., Doody J., Massague J., Inhibition of transforming growth factor- /SMAD signalling by the interferon- /STAT pathway Nature 1999 397 6721 710 713
42. Tracey K. J., Cerami A., Tumor necrosis factor: a pleiotropic cytokine and therapeutic target Annual Review of Medicine 1994 45 491 503
43. Ulloa L., Messmer D., High-mobility group box 1 (HMGB1) protein: friend and foe Cytokine and Growth Factor Reviews 2006 17 3 189 201
44. Hildebrand F., Hubbard W. J., Choudhry M. A., Kupffer cells and their mediators: the culprits in producing distant organ damage after trauma-hemorrhage American Journal of Pathology 2006 169 3 784 794
45. Keel M., Trentz O., Pathophysiology of polytrauma Injury 2005 36 6 691 709
46. Li C., Jackson R. M., Reactive species mechanisms of cellular hypoxia-reoxygenation injury American Journal of Physiology 2002 282 2 C227 C241
47. Claridge J. A., Schulman A. M., Young J. S., Improved resuscitation minimizes respiratory dysfunction and blunts interleukin-6 and nuclear factor- B activation after traumatic hemorrhage Critical Care Medicine 2002 30 8 1815 1819
48. Lee C.-C., Chang I.-J., Yen Z.-S., Shock induces proinflammatory cytokine response Annals of Emergency Medicine 2007 49 1 37 44
49. Santibanez-Gallerani A.S., Barber A. E., Williams S. J., Zhao Y., Shires G. T., Improved survival with early fluid resuscitation following hemorrhagic shock World Journal of Surgery 2001 25 5 592 597
50. Masuno T., Moore E. E., Cheng A. M., Sarin E. L., Banerjee A., Bioactivity of postshock mesenteric lymph depends on the depth and duration of hemorrhagic shock Shock 2006 26 3 285 289
51. Donnahoo K. K., Shames B. D., Harken A. H., Meldrum D. R., The role of tumor necrosis factor in renal ischemia-reperfusion injury Journal of Urology 1999 162 1 196 203
52. Suitters A. J., Foulkes R., Opal S. M., Differential effect of isotype on efficacy of anti-tumor necrosis factor chimeric antibodies in experimental septic shock Journal of Experimental Medicine 1994 179 3 849 856
53. Suzuki K., Hino M., Kutsuna H., Selective activation of p38 mitogen-activated protein kinase cascade in human neutrophils stimulated by IL-1 Journal of Immunology 2001 167 10 5940 5947
54. Tawadrous Z. S., Delude R. L., Fink M. P., Resuscitation from hemorrhagic shock with Ringer's ethyl pyruvate solution improves survival and ameliorates intestinal mucosal hyperpermeability in rats Shock 2002 17 6 473 477
55. Yang R., Gallo D. J., Baust J. J., Ethyl pyruvate modulates inflammatory gene expression in mice subjected to hemorrhagic shock American Journal of Physiology 2002 283 1 G212 G221
56. Mulier K. E., Beilman G. J., Conroy M. J., Taylor J. H., Skarda D. E., Hammer B. E., Ringer's ethyl pyruvate in hemorrhagic shock and resuscitation does not improve early hemodynamics or tissue energetics Shock 2005 23 3 248 252
57. Parrish W., Ulloa L., High-mobility group box-1 isoforms as potential therapeutic targets in sepsis Methods in Molecular Biology 2007 361 145 162
58. Mantell L. L., Parrish W. R., Ulloa L., HMGB-1 as a therapeutic target for infectious and inflammatory disorders Shock 2006 25 1 4 11
59. Li W., Sama A. E., Wang H., Role of HMGB1 in cardiovascular diseases Current Opinion in Pharmacology 2006 6 2 130 135
60. Wang H., Czura C. J., Tracey K. J., Lipid unites disparate syndromes of sepsis Nature Medicine 2004 10 2 124 125
61. Hotchkiss R. S., Karl I. E., The pathophysiology and treatment of sepsis The New England Journal of Medicine 2003 348 2 138 150
62. Tracey K. J., Cerami A., Tumor necrosis factor: a pleiotropic cytokine and therapeutic target Annual Review of Medicine 1994 45 491 503
63. Peterson B. T., Miller E. J., Griffith D. E., Rowjee R., McWaters P., Modulation by pentobarbital of neutrophil responses to inhaled E. coli endotoxin in sheep: role of lung epithelium European Respiratory Journal 2000 16 4 697 703
64. Wang J., Charboneau R., Balasubramanian S., Barke R. A., Loh H. H., Roy S., The immunosuppressive effects of chronic morphine treatment are partially dependent on corticosterone and mediated by the -opioid receptor Journal of Leukocyte Biology 2002 71 5 782 790
65. Tsukamoto T., Pape H. C., Animal models for trauma research: what are the options? Shock 2009 31 1 3 10
66. Frankel D. A. Z., Acosta J. A., Anjaria D. J., Physiologic response to hemorrhagic shock depends on rate and means of hemorrhage Journal of Surgical Research 2007 143 2 276 280
67. Cai B., Dong W., Sharpe S, Deitch E. A., Ulloa L., Survival and inflammatory responses in experimental models of hemorrhage. Journal of Surgical Research, 2009 December 9. [Epub ahead of print]
68. Giroir B. P., Horton J. W., White D. J., McIntyre K. L., Lin C. Q., Inhibition of tumor necrosis factor prevents myocardial dysfunction during burn shock American Journal of Physiology 1994 267 1 H118 H124
69. Upperman J. S., Deitch E. A., Guo W., Lu Q., Xu D., Post-hemorrhagic shock mesenteric lymph is cytotoxic to endothelial cells and activates neutrophils Shock 1998 10 6 407 414
70. Sato H., Kasai K., Tanaka T., Kita T., Tanaka N., Role of tumor necrosis factor- and interleukin-1 on lung dysfunction following hemorrhagic shock in rats Medical Science Monitor 2008 14 5 BR79 BR87
71. Wang M., Sankula R., Tsai B. M., P38 MAPK mediates myocardial proinflammatory cytokine production and endotoxin-induced contractile suppression Shock 2004 21 2 170 174
72. Meldrum D. R., Tumor necrosis factor in the heart American Journal of Physiology 1998 274 3 R577 R595
73. Cain B. S., Meldrum D. R., Dinarello C. A., Tumor necrosis factor- and interleukin-1 synergistically depress human myocardial function Critical Care Medicine 1999 27 7 1309 1318
74. Bowden R. A., Ding Z.-M., Donnachie E. M., Role of 4 integrin and VCAM-1 in CD18-independent neutrophil migration across mouse cardiac endothelium Circulation Research 2002 90 5 562 569
75. Yao Y.-M., Redl H., Bahrami S., Schlag G., The inflammatory basis of trauma/shock-associated multiple organ failure Inflammation Research 1998 47 5 201 210
76. Liu L. M., Hu D. Y., Chen H. S., Hu P. H., The effect of different volumes of fluid resuscitation on traumatichemorrhagic shock at high altitude in the unacclimated rat Shock 2004 21 93 96
77. Maulik N., Sato M., Price B. D., Das D. K., An essential role of NF B in tyrosine kinase signaling of p38 MAP kinase regulation of myocardial adaptation to ischemia FEBS Letters 1998 429 3 365 369
78. See F., Thomas W., Way K., P38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat Journal of the American College of Cardiology 2004 44 8 1679 1689
79. Meldrum D. R., Dinarello C. A., Cleveland J.C. Jr., Hydrogen peroxide induces tumor necrosis factor -mediated cardiac injury by a P38 mitogen-activated protein kinase-dependent mechanism Surgery 1998 124 2 291 297
80. Craig R., Larkin A., Mingo A. M., p38 MAPK and NF- B collaborate to induce interleukin-6 gene expression and release: evidence for a cytoprotective autocrine signaling pathway in a cardiac myocyte model system Journal of Biological Chemistry 2000 275 31 23814 23824
81. Kaiser R. A., Bueno O. F., Lips D. J., Targeted inhibition of p38 mitogen-activated protein kinase antagonizes cardiac injury and cell death following ischemia-reperfusion in vivo Journal of Biological Chemistry 2004 279 15 15524 15530
82. Kakkar A. K., Lefer D. J., Leukocyte and endothelial adhesion molecule studies in knockout mice Current Opinion in Pharmacology 2004 4 2 154 158
83. Poon B. Y., Ward C. A., Giles W. R., Kubes P., Emigrated neutrophils regulate ventricular contractility via 4 integrin Circulation Research 1999 84 11 1245 1251
84. Reinhardt P. H., Ward C. A., Giles W. R., Kubes P., Emigrated rat neutrophils adhere to cardiac myocytes via 4 integrin Circulation Research 1997 81 2 196 201
85. Neviere R. R., Cepinskas G., Madorin W. S., LPS pretreatment ameliorates peritonitis-induced myocardial inflammation and dysfunction: role of myocytes American Journal of Physiology 1999 277 3 H885 H892
86. Sy J. C., Seshadri G., Yang S. C., Sustained release of a p38 inhibitor from non-inflammatory microspheres inhibits cardiac dysfunction Nature Materials 2008 7 11 863 868
87. Ayala A., Chaudry I. H., Immune dysfunction in murine polymicrobial sepsis: mediators, macrophages, lymphocytes and apoptosis Shock 1996 6 6, supplement 1 27 38
88. Pfeffer K., Matsuyama T., Kndig T. M., Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection Cell 1993 73 3 457 467
89. Giamarellos-Bourboulis E.J., Immunomodulatory therapies for sepsis: unexpected effects with macrolides International Journal of Antimicrobial Agents 2008 32 supplement 1 S39 S43
90. Jean-Baptiste E., Cellular mechanisms in sepsis Journal of Intensive Care Medicine 2007 22 2 63 72
91. Dinarello C. A., Thompson R. C., Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro Immunology Today 1991 12 11 404 410
92. Block M. I., Berg M., McNamara M. J., Norton J. A., Fraker D. L., Alexander H. R., Passive immunization of mice against D factor blocks lethality and cytokine release during endotoxemia Journal of Experimental Medicine 1993 178 3 1085 1090
93. Waring P. M., Waring L. J., Metcalf D., Circulating leukemia inhibitory factor levels correlate with disease severity in meningococcemia Journal of Infectious Diseases 1994 170 5 1224 1228
94. Liew C. Y., Tham C. L., Lam K. W., A synthetic hydroxypropenone inhibits nitric oxide, prostaglandin E2, and proinflammatory cytokine synthesis. Immunopharmacology and Immunotoxico, 2010 January 28. [Epub ahead of print]
95. Hauser C. J., Lagoo S., Lagoo A., Tumor necrosis factor gene expression in human peritoneal macrophages is suppressed by extra-abdominal trauma Archives of Surgery 1995 130 11 1186 1192
96. Miller-Graziano C. L., Szabo G., Griffey K., Mehta B., Kodys K., Catalano D., Role of elevated monocyte transforming growth factor (TGF) production in posttrauma immunosuppression Journal of Clinical Immunology 1991 11 2 95 102
97. Borovikova L. V., Ivanova S., Zhang M., Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin Nature 2000 405 6785 458 462
98. Sands K. E., Bates D. W., Lanken P. N., Epidemiology of sepsis syndrome in 8 academic medical centers Journal of the American Medical Association 1997 278 3 234 240
99. Rushing G. D., Britt L. D., Reperfusion injury after hemorrhage: a collective review Annals of Surgery 2008 247 6 929 937
100. Rajani R. R., Ball C. G., Feliciano D. V., Vercruysse G. A., Vasopressin in hemorrhagic shock: review article American Surgeon 2009 75 12 1207 1212